Suppr超能文献

COVID-19 与非 COVID-19 危重症期间胰岛素需求轨迹:一项回顾性队列研究。

Insulin requirement trajectories during COVID-19 versus non-COVID-19 critical illness-A retrospective cohort study.

机构信息

Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.

Department of Physiology and Pharmacology, Section of Anaesthesia and Intensive Care, Karolinska Institutet, Stockholm, Sweden.

出版信息

Acta Anaesthesiol Scand. 2025 Jan;69(1):e14536. doi: 10.1111/aas.14536. Epub 2024 Oct 14.

Abstract

BACKGROUND

The glycemic response to critical COVID-19 remains uncertain. We aimed to assess the association between COVID-19, insulin requirements, glycemic control, and mortality in intensive care unit (ICU) patients.

METHODS

We conducted a retrospective observational study of 350 COVID-19 patients and 1067 non-COVID-19 patients admitted to the ICU. Insulin requirement was defined as the total units of exogenous insulin required to cover one gram of administered carbohydrates (insulin-to-carbohydrate ratio, ICR). We used multivariable generalized linear mixed-model (GLMM) analysis to assess the association of the interaction between COVID-19 and ICU-day with daily ICR, adjusted for fixed and time-dependent covariates. Glycemic control was assessed after stratification on diabetes and COVID-19. We used multivariable logistic regression analysis to assess the association between ICR and 90-day mortality.

RESULTS

The mean (95% CI) of the mean daily ICR among patients without diabetes was 0.09 (0.08-0.11) U/g and 0.15 (0.11-0.18) U/g in the non-COVID-19 group and COVID-19 group (p = .01), respectively. In diabetes patients, the corresponding ICRs were 0.52 (0.43-0.62) U/g and 0.59 (0.50-0.68) U/g (p = .32). In multivariable GLMM analysis, the interaction between COVID-19 and ICU-day was independently associated with ICR (risk estimate 1.22, 95% CI 1.15-1.31, p < .001). COVID-19 was associated with higher hypoglycemia prevalence irrespective of diabetes status, higher average glucose levels, more pronounced glucose variability, and a lower proportion of glucose values within target range among patients without diabetes. On multivariable logistic regression analysis, the adjusted odds ratio for 90-day mortality was 1.77 (95% CI 0.94-3.34, p = .076) per one unit increase in mean ICR.

CONCLUSION

In our cohort of ICU patients, COVID-19 was associated with higher daily insulin requirements per gram of administered carbohydrates, and worse glycemic control. We found no robust association between ICR and increased odds of death at 90 days.

摘要

背景

新冠肺炎患者的血糖反应仍不确定。我们旨在评估新冠肺炎、胰岛素需求、血糖控制和重症监护病房(ICU)患者死亡率之间的关系。

方法

我们对 350 名新冠肺炎患者和 1067 名非新冠肺炎患者进行了回顾性观察性研究。胰岛素需求定义为覆盖给予的 1 克碳水化合物所需的外源性胰岛素总量(胰岛素-碳水化合物比,ICR)。我们使用多变量广义线性混合模型(GLMM)分析来评估 COVID-19 和 ICU 天数之间的相互作用与每日 ICR 的关系,调整了固定和时间依赖性协变量。在分层糖尿病和 COVID-19 后评估血糖控制情况。我们使用多变量逻辑回归分析来评估 ICR 与 90 天死亡率之间的关系。

结果

无糖尿病患者的平均每日 ICR 分别为 0.09(0.08-0.11)U/g 和 0.15(0.11-0.18)U/g,非 COVID-19 组和 COVID-19 组分别为 0.09(0.08-0.11)U/g 和 0.15(0.11-0.18)U/g(p=0.01)。在糖尿病患者中,相应的 ICR 分别为 0.52(0.43-0.62)U/g 和 0.59(0.50-0.68)U/g(p=0.32)。在多变量 GLMM 分析中,COVID-19 和 ICU 天数之间的相互作用与 ICR 独立相关(风险估计值 1.22,95%CI 1.15-1.31,p<0.001)。无论糖尿病状态如何,COVID-19 与更高的低血糖发生率、更高的平均血糖水平、更明显的血糖变异性以及糖尿病患者血糖值处于目标范围内的比例较低有关。在多变量逻辑回归分析中,平均 ICR 每增加 1 个单位,90 天死亡率的调整比值比为 1.77(95%CI 0.94-3.34,p=0.076)。

结论

在我们的 ICU 患者队列中,COVID-19 与每克给予的碳水化合物所需的胰岛素日剂量增加有关,且血糖控制更差。我们没有发现 ICR 与 90 天死亡率增加之间存在稳健的关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验